BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37724014)

  • 1. Tailoring CONSORT-SPI to improve the reporting of smoking cessation intervention trials: An expert consensus study.
    Swithenbank Z; Bricca A; Black N; Hartmann Boyce J; Johnston M; Scott N; West R; Courtney RJ; Treweek S; Michie S; de Bruin M
    Addiction; 2024 Feb; 119(2):225-235. PubMed ID: 37724014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reporting randomised trials of social and psychological interventions: the CONSORT-SPI 2018 Extension.
    Montgomery P; Grant S; Mayo-Wilson E; Macdonald G; Michie S; Hopewell S; Moher D;
    Trials; 2018 Jul; 19(1):407. PubMed ID: 30060754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CONSORT-SPI 2018 Explanation and Elaboration: guidance for reporting social and psychological intervention trials.
    Grant S; Mayo-Wilson E; Montgomery P; Macdonald G; Michie S; Hopewell S; Moher D;
    Trials; 2018 Jul; 19(1):406. PubMed ID: 30060763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for reporting pediatric and child health clinical trial protocols and reports: study protocol for SPIRIT-Children and CONSORT-Children.
    Baba A; Smith M; Potter BK; Chan AW; Moher D; Offringa M
    Trials; 2024 Jan; 25(1):96. PubMed ID: 38287439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methods used to develop the SPIRIT 2024 and CONSORT 2024 Statements.
    Tunn R; Boutron I; Chan AW; Collins GS; Hróbjartsson A; Moher D; Schulz KF; de Beyer JA; Hansen Nejstgaard C; Østengaard L; Hopewell S
    J Clin Epidemiol; 2024 May; 169():111309. PubMed ID: 38428538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement.
    Gates M; Gates A; Pieper D; Fernandes RM; Tricco AC; Moher D; Brennan SE; Li T; Pollock M; Lunny C; Sepúlveda D; McKenzie JE; Scott SD; Robinson KA; Matthias K; Bougioukas KI; Fusar-Poli P; Whiting P; Moss SJ; Hartling L
    BMJ; 2022 Aug; 378():e070849. PubMed ID: 35944924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension.
    Butcher NJ; Monsour A; Mew EJ; Chan AW; Moher D; Mayo-Wilson E; Terwee CB; Chee-A-Tow A; Baba A; Gavin F; Grimshaw JM; Kelly LE; Saeed L; Thabane L; Askie L; Smith M; Farid-Kapadia M; Williamson PR; Szatmari P; Tugwell P; Golub RM; Monga S; Vohra S; Marlin S; Ungar WJ; Offringa M
    JAMA; 2022 Dec; 328(22):2252-2264. PubMed ID: 36511921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protocol for CONSORT-SPI: an extension for social and psychological interventions.
    Montgomery P; Grant S; Hopewell S; Macdonald G; Moher D; Michie S; Mayo-Wilson E
    Implement Sci; 2013 Sep; 8():99. PubMed ID: 24004579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methods and results used in the development of a consensus-driven extension to the Consolidated Standards of Reporting Trials (CONSORT) statement for trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE).
    Imran M; Kwakkenbos L; McCall SJ; McCord KA; Fröbert O; Hemkens LG; Zwarenstein M; Relton C; Rice DB; Langan SM; Benchimol EI; Thabane L; Campbell MK; Sampson M; Erlinge D; Verkooijen HM; Moher D; Boutron I; Ravaud P; Nicholl J; Uher R; Sauvé M; Fletcher J; Torgerson D; Gale C; Juszczak E; Thombs BD
    BMJ Open; 2021 Apr; 11(4):e049093. PubMed ID: 33926985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving outcome reporting in clinical trial reports and protocols: study protocol for the Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT).
    Butcher NJ; Monsour A; Mew EJ; Szatmari P; Pierro A; Kelly LE; Farid-Kapadia M; Chee-A-Tow A; Saeed L; Monga S; Ungar W; Terwee CB; Vohra S; Fergusson D; Askie LM; Williamson PR; Chan AW; Moher D; Offringa M
    Trials; 2019 Mar; 20(1):161. PubMed ID: 30841935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.
    Turner L; Shamseer L; Altman DG; Weeks L; Peters J; Kober T; Dias S; Schulz KF; Plint AC; Moher D
    Cochrane Database Syst Rev; 2012 Nov; 11(11):MR000030. PubMed ID: 23152285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferred Reporting Items for RAndomized Trials in Endodontics (PRIRATE) guidelines: a development protocol.
    Nagendrababu V; Duncan HF; Bjørndal L; Kvist T; Priya E; Pulikkotil SJ; Jayaraman J; Dummer PMH
    Int Endod J; 2019 Jul; 52(7):974-978. PubMed ID: 30702139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension.
    Liu X; Cruz Rivera S; Moher D; Calvert MJ; Denniston AK;
    Lancet Digit Health; 2020 Oct; 2(10):e537-e548. PubMed ID: 33328048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI Extension.
    Liu X; Rivera SC; Moher D; Calvert MJ; Denniston AK;
    BMJ; 2020 Sep; 370():m3164. PubMed ID: 32909959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE study.
    Solovyeva O; Dimairo M; Weir CJ; Hee SW; Espinasse A; Ursino M; Patel D; Kightley A; Hughes S; Jaki T; Mander A; Evans TRJ; Lee S; Hopewell S; Rantell KR; Chan AW; Bedding A; Stephens R; Richards D; Roberts L; Kirkpatrick J; de Bono J; Yap C
    BMC Med; 2023 Jul; 21(1):246. PubMed ID: 37408015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development process of a consensus-driven CONSORT extension for randomised trials using an adaptive design.
    Dimairo M; Coates E; Pallmann P; Todd S; Julious SA; Jaki T; Wason J; Mander AP; Weir CJ; Koenig F; Walton MK; Biggs K; Nicholl J; Hamasaki T; Proschan MA; Scott JA; Ando Y; Hind D; Altman DG
    BMC Med; 2018 Nov; 16(1):210. PubMed ID: 30442137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reporting Guidelines for Clinical Trial Protocols and Reports of Implantable Neurostimulation Devices: Protocol for the SPIRIT-iNeurostim and CONSORT-iNeurostim Extensions.
    Duarte RV; Bresnahan R; Copley S; Eldabe S; Thomson S; North RB; Baranidharan G; Levy RM; Taylor RS;
    Neuromodulation; 2022 Oct; 25(7):1045-1049. PubMed ID: 35088759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension.
    Liu X; Cruz Rivera S; Moher D; Calvert MJ; Denniston AK;
    Nat Med; 2020 Sep; 26(9):1364-1374. PubMed ID: 32908283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Single-Case Reporting Guideline In Behavioural Interventions (SCRIBE) 2016 statement.
    Tate RL; Perdices M; Rosenkoetter U; Shadish W; Vohra S; Barlow DH; Horner R; Kazdin A; Kratochwill T; McDonald S; Sampson M; Shamseer L; Togher L; Albin R; Backman C; Douglas J; Evans JJ; Gast D; Manolov R; Mitchell G; Nickels L; Nikles J; Ownsworth T; Rose M; Schmid CH; Wilson B
    Can J Occup Ther; 2016 Jun; 83(3):184-95. PubMed ID: 27231387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.